https://www.selleckchem.com/pr....oducts/Dapagliflozin
Osteogenesis imperfecta (OI) is a heterogeneous connective tissue disorder characterized by repeated fractures and skeletal disorders. At present, bisphosphonate (BP) therapy is the gold standard for OI treatment. The present retrospective study evaluated the effect of BP therapy on tooth development and eruption of permanent teeth in a cohort of children receiving pamidronate. Three groups were studied patients with OI who were treated with BPs (n = 45), patients with OI who were not treated with BPs (n = 117), and age- and gende
Curtir
Comentario
Compartilhar
